Fonseca F V, Antunes E, Morganti R P, Monteiro Helena S A, Martins A M C, Toyama D O, Marangoni S, Toyama M H
Departamento de Bioquímica, Instituto de Biologia (IB), Campinas, SP, Brasil.
Protein J. 2006 Apr;25(3):183-92. doi: 10.1007/s10930-006-9001-z.
In this article we investigated the platelet aggregating activity of whole crotoxin and its subunits isolated from Crotalus durissus cascavella venom. During the purification protocols of the venom, using HPLC molecular exclusion, we detected the presence of two different serine protease activities in the gyroxin fraction, and another in the crotoxin fraction, which induced strong and irreversible platelet aggregation, in addition to blood coagulation. From crotoxin, we isolated PLA2, crotapotin (both fractions corresponding approximately 85% of whole crotoxin) and another minor fraction (F20) that exhibited serine protease activity. After a new fractionation on reverse phase HPLC chromatography, we obtained three other fractions named as F201, F202 and F203. F202 was obtained with high degree of molecular homogeneity with molecular mass of approximately 28 kDa and a high content of acidic amino residues, such as aspartic acid and glutamic acid. Other important amino acids were histidine, cysteine and lysine. This protein exhibited a high specificity for BApNA, a Michaelis-Menten behavior with Vmax estimated in 5.64 microM/min and a Km value of 0.58 mM for this substrate. In this work, we investigated the ability of F202 to degrade fibrinogen and observed alpha and beta chain cleavage. Enzymatic as well as the platelet aggregation activities were strongly inhibited when incubated with TLCK and PMSF, specific inhibitors of serine protease. Also, F202 induced platelet aggregation in washed and platelet-rich plasma, and in both cases, TLCK inhibited its activity. The N-terminal amino acid sequence of F202 presented a high amino acid sequence homology with other thrombin-like proteins, but it was significantly different from gyroxin. These results showed that crotoxin is a highly heterogeneous protein composed of PLA2, thrombin-like and other fractions that might explain the diversity of physiological and pharmacological activities of this protein.
在本文中,我们研究了从南美响尾蛇毒液中分离出的全响尾蛇毒素及其亚基的血小板聚集活性。在毒液的纯化过程中,使用高效液相色谱分子排阻法,我们在陀螺毒素组分中检测到两种不同的丝氨酸蛋白酶活性,在响尾蛇毒素组分中检测到另一种丝氨酸蛋白酶活性,它们除了引起血液凝固外,还诱导强烈且不可逆的血小板聚集。从响尾蛇毒素中,我们分离出磷脂酶A2、响尾蛇毒素轻链(这两个组分约占全响尾蛇毒素的85%)以及另一个具有丝氨酸蛋白酶活性的次要组分(F20)。在反相高效液相色谱上进行新的分级分离后,我们得到了另外三个组分,命名为F201、F202和F203。F202具有高度的分子同质性,分子量约为28 kDa,含有高含量的酸性氨基酸残基,如天冬氨酸和谷氨酸。其他重要的氨基酸有组氨酸、半胱氨酸和赖氨酸。这种蛋白质对BApNA具有高度特异性,呈现米氏动力学行为,Vmax估计为5.64 μM/min,对该底物的Km值为0.58 mM。在这项工作中,我们研究了F202降解纤维蛋白原的能力,并观察到α链和β链的裂解。当与丝氨酸蛋白酶的特异性抑制剂TLCK和PMSF一起孵育时,酶活性以及血小板聚集活性均受到强烈抑制。此外,F202在洗涤过的血浆和富含血小板的血浆中均诱导血小板聚集,在这两种情况下,TLCK均抑制其活性。F202的N端氨基酸序列与其他类凝血酶蛋白具有高度的氨基酸序列同源性,但与陀螺毒素有显著差异。这些结果表明,响尾蛇毒素是一种高度异质性的蛋白质,由磷脂酶A2、类凝血酶和其他组分组成,这可能解释了该蛋白质生理和药理活性的多样性。